Alyson Haslam

Alyson Haslam

University of California San Francisco - San Francisco / United States
Medical and Health Sciences / Epidemiology and Public Health
AD Scientific Index ID: 1878105
person_outline Alyson Haslam's MOST POPULAR ARTICLES
1-) Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugsA Haslam, V PrasadJAMA network open 2 (5), e192535-e192535, 20196352019
2-) Estimation of the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugsA Haslam, J Gill, V PrasadJAMA network open 3 (3), e200423-e200423, 20201632020
3-) A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncologyA Haslam, SP Hey, J Gill, V PrasadEuropean Journal of Cancer 106, 196-211, 20191542019
4-) A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversalsD Herrera-Perez, A Haslam, T Crain, J Gill, C Livingston, V Kaestner, ...Elife 8, e45183, 20191232019
5-) FDA acceptance of surrogate end points for cancer drug approval: 1992-2019EY Chen, A Haslam, V PrasadJAMA internal medicine 180 (6), 912-914, 2020852020